PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY PADA PENYAKIT ARTERI PERIFER YANG TIDAK BERESPON TERAPI MEDIKAMENTOSA: LAPORAN KASUS

PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY IN PERIPHERAL ARTERY DISEASE UNRESPONSIVE TO MEDICAL THERAPY: A CASE REPORT

  • Agustiawan Fakultas Kedokteran Institut Kesehatan Helvetia Medan
  • Juwanto Fakultas Kedokteran Universitas Riau
Keywords: Angioplasti, Arteri perifer, Klaudikasio, Oklusi

Abstract

Pendahuluan: Penyakit arteri perifer (PAP) merupakan manifestasi penyakit kardiovaskular yang sering ditemukan di negara berkembang, termasuk Indonesia. Prevalensi PAP dilaporkan mencapai 8–28% dan berkontribusi besar terhadap kecacatan. Laporan kasus ini menggambarkan keberhasilan percutaneous transluminal angioplasty (PTA) pada pasien PAP yang tidak membaik dengan terapi farmakologis. Laporan Kasus: Seorang wanita 66 tahun datang dengan PAP grade Rutherford 3–4 pada tungkai bawah kanan. Pasien memiliki riwayat PAP pada tungkai kiri dan pernah menjalani PTA. Ia mengeluhkan klaudikasio berat dengan jarak tempuh <30 meter dan nyeri yang kadang tidak hilang saat istirahat. Terapi cilostazol tidak memberikan perbaikan bermakna. Pemeriksaan fisik menunjukkan pulsasi arteri dorsalis pedis kanan melemah, ekstremitas kanan lebih dingin, dan saturasi oksigen jari kaki 92–94%, tanpa lesi kulit. CTA mengungkap oklusi arteri tibialis anterior dan posterior hingga arteri plantaris dan dorsalis pedis kanan. PTA dilakukan dengan hasil baik dan perbaikan gejala pada kontrol berikutnya. Kesimpulan: Percutaneous transluminal angioplasty dapat menjadi pilihan terapi efektif bagi pasien PAP Rutherford 3–4 yang tidak menunjukkan respons adekuat terhadap terapi medikamentosa.

References

Zipes D, Libby P, Bonow R. Braunwald’s Heart Disease. 8th ed. Elsevier; 2019.

Campia U, Gerhard-Herman M, Piazza G, Goldhaber SZ. Peripheral artery disease: past, present, and future. Am J Med. 2019;132(10):1133-1141.

Song P, Rudan D, Zhu Y, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Heal. 2019;7(8):e1020-e1030.

Cook IO, Chung J. Contemporary medical management of peripheral arterial disease. Cardiovasc Drugs Ther. 2025;39(2):357-371.

Habib A; Petrucci G; Rocca B. Pathophysiology of Thrombosis in Peripheral Artery Disease. Curr Vasc Pharmacol. Published online 2019.

Shamaki GR, Markson F, Soji-Ayoade D, Agwuegbo CC, Bamgbose MO, Tamunoinemi BM. Peripheral artery disease: a comprehensive updated review. Curr Probl Cardiol. 2022;47(11):101082.

Søgaard M, Behrendt CA, Eldrup N, Skjøth F. Lifetime risk of lower extremity peripheral arterial disease: a Danish nationwide longitudinal study. Eur Heart J. 2025;46(13):1206-1215.

Hischke S, Riess HC, Bublitz MK, et al. Quality indicators in peripheral arterial occlusive disease treatment: a systematic review. Eur J Vasc Endovasc Surg. 2019;58(5):738-745.

Bevan GH, White Solaru KT. Evidence-based medical management of peripheral artery disease. Arterioscler Thromb Vasc Biol. 2020;40(3):541-553.

Ram N. Peripheral arterial disease (PAD) in diabetics: diagnosis and management-a narrative review. J Pak Med Assoc. 2023;73(3):621-626.

Golledge J. Update on the pathophysiology and medical treatment of peripheral artery disease. Nat Rev Cardiol. 2022;19(7):456-474.

Mahfouz MF, Salama TMS, Afifi AH, Dabous HMK. Effectiveness and early postoperative outcomes of palliative endoluminal stenting versus Hartmann’s procedure in acute malignant bowel obstruction in high-risk patients. Ann Coloproctol. 2022;38(2):141-145. doi:10.3393/ac.2021.01.28

Meloni M, Vas PRJ. Peripheral arterial disease in diabetic foot: One disease with multiple patterns. J Clin Med. 2025;14(6):1987.

Ghirardini F, Martini R. Current opinion on diagnosis of peripheral artery disease in diabetic patients. Medicina (B Aires). 2024;60(7):1179.

Nordanstig J, Behrendt CA, Bradbury AW, et al. Peripheral arterial disease (PAD)–A challenging manifestation of atherosclerosis. Prev Med (Baltim). 2023;171:107489.

Hardman RL, Jazaeri O, Yi J, et al. Overview of Classification Systems in Peripheral Artery Disease. Semin Interv Radiol. 2014;31(4):378-388.

Abramson BL, Al-Omran M, Anand SS, et al. Canadian Cardiovascular Society 2022 guidelines for peripheral arterial disease. Can J Cardiol. 2022;38(5):560-587.

Hardung D, Behne A, Boral M, Giesche C, Langhoff R. Antithrombotic treatment for peripheral arterial occlusive disease. Dtsch Arztebl Int. 2021;118(31-32):528.

Martini R, Ageno W, Amato C, Favaretto E, Porfidia A, Visonà A. Cilostazol for peripheral arterial disease–a position paper from the Italian Society for Angiology and Vascular Medicine. Vasa. Published online 2024.

Criqui MH, Matsushita K, Aboyans V, et al. Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association. Circulation. 2021;144(9):e171-e191.

Published
2025-12-01
Section
Laporan Kasus